Mobile

A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Three-Treatment, Three 6-Week Period Cross-Over, Multi-Center Exploratory Study to Evaluate the Effect of Adding GSK2190915 300mg Tablets ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-019989-91

A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Three-Treatment, Three 6-Week Period Cross-Over, Multi-Center Exploratory Study to Evaluate the Effect of Adding GSK2190915 300mg Tablets Once Daily, Montelukast 10mg Tablets Once Daily or Placebo Tablets Once Daily to Fluticasone Propionate 250mcg/Salmeterol 50mcg Inhalation Powder Twice Daily in Uncontrolled Asthmatic Subjects > 18 Years of Age

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Evaluate the efficacy and safety of adding GSK2190915 300mg or placebo tablets administered once daily to FP/SAL 250/50mcg inhalation powder administered twice daily in uncontrolled asthmatic subjects ≥18 years of age over the course of 6 weeks treatment.

Critère d'inclusion

  • Asthma

Liens